Want to see SGRY full AI Analyst Report?
SGRY Stock Chart & Stats
$14.05
-$0.23(-1.46%)
At close: 4:00 PM EDT
$14.05
-$0.23(-1.46%)
Day’s Range― - ―
52-Week Range$11.41 - $23.44
Previous CloseN/A
Volume650.92K
Average Volume (3M)1.98M
Market Cap
$1.93B
Enterprise Value$7.80B
Total Cash (Recent Filing)$216.70M
Total Debt (Recent Filing)$4.02B
Price to Earnings (P/E)―
Beta1.21
Next Earnings
Nov 10, 2026EPS Estimate
0.12Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.69
Shares Outstanding130,918,260
10 Day Avg. Volume1,351,523
30 Day Avg. Volume1,978,292
Financial Highlights & Ratios
PEG Ratio0.47
Price to Book (P/B)1.15
Price to Sales (P/S)0.59
P/FCF Ratio10.05
Enterprise Value/Market Cap4.05
Enterprise Value/Revenue2.32
Enterprise Value/Gross Profit10.85
Enterprise Value/Ebitda8.23
Forecast
1Y Price Target
$18.43Price Target Upside31.16% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering8
EPS Forecast (FY)0.41
Revenue Forecast (FY)$3.35B
Bulls Say, Bears Say
Bulls Say
Organic Growth And Physician RecruitmentSame-facility growth and continued physician recruitment support a durable volume engine for the surgical network. More aligned physicians can direct additional procedures to company facilities, while case and acuity growth may strengthen utilization and revenue per center over the next several quarters.
Debt Reduction Through Hospital DivestitureThe completed asset sale materially reshapes the portfolio and provides substantial proceeds for debt reduction. Lower leverage would improve financial flexibility, reduce interest burden over time, and allow management to focus capital and operating resources on its core short-stay surgical strategy.
Reaffirmed Operating OutlookReaffirmed revenue and adjusted EBITDA targets provide evidence that management still expects the operating platform to deliver meaningful scale and profitability. Maintaining guidance despite portfolio changes supports near-term planning confidence and indicates continued focus on organic execution and expense discipline.
Bears Say
Elevated Leverage And Interest BurdenHigh leverage remains a structural constraint even after the divestiture, limiting financial flexibility and increasing sensitivity to operating volatility. The sizeable interest burden absorbs cash that could otherwise fund growth or facility development, making successful debt reduction and execution especially important.
Persistent Losses And Weaker Free Cash FlowPositive operating cash flow has not yet translated into durable bottom-line profitability, and the sharp free-cash-flow decline indicates weaker cash conversion or greater spending needs. Continued losses and less robust cash generation could constrain debt repayment, investment capacity, and shareholder returns.
EBITDA Margin PressureDeclining adjusted EBITDA and margin show that revenue growth is not currently converting into stronger operating earnings. If cost ratios remain elevated, especially in labor and supplies, operating leverage may stay limited and make it harder to offset interest expense or support consistent net profitability.
Surgery Partners News
SGRY FAQ
What was Surgery Partners Inc’s price range in the past 12 months?
Surgery Partners Inc lowest stock price was $11.41 and its highest was $23.44 in the past 12 months.
What is Surgery Partners Inc’s market cap?
Surgery Partners Inc’s market cap is $1.93B.
When is Surgery Partners Inc’s upcoming earnings report date?
Surgery Partners Inc’s upcoming earnings report date is Nov 10, 2026 which is in 20 days.
How were Surgery Partners Inc’s earnings last quarter?
Surgery Partners Inc released its earnings results on Aug 10, 2026. The company reported $0.1 earnings per share for the quarter, beating the consensus estimate of $0.058 by $0.042.
Is Surgery Partners Inc overvalued?
According to Wall Street analysts Surgery Partners Inc’s price is currently Undervalued.
Does Surgery Partners Inc pay dividends?
Surgery Partners Inc does not currently pay dividends.
What is Surgery Partners Inc’s EPS estimate?
Surgery Partners Inc’s EPS estimate is 0.12.
How many shares outstanding does Surgery Partners Inc have?
Surgery Partners Inc has 130,918,260 shares outstanding.
What happened to Surgery Partners Inc’s price movement after its last earnings report?
Surgery Partners Inc reported an EPS of $0.1 in its last earnings report, beating expectations of $0.058. Following the earnings report the stock price went up 2.704%.
Which hedge fund is a major shareholder of Surgery Partners Inc?
Currently, no hedge funds are holding shares in SGRY
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Surgery Partners Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$18.43 (31.16% Upside)
$18.43 (31.16% Upside)
Blogger Sentiment
Bullish
SGRY Sentiment 67%
Sector Average 67%
Sector Average 67%
Hedge Fund Trend
Decreased
By 1.8M Shares
Last Quarter.
Last Quarter.
Insider Transactions
Bought Shares
Worth $143.5K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Neutral
Last 7 Days ▼ 1.0%
Last 30 Days ▲ 0.7%
Last 30 Days ▲ 0.7%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-28.55%
12-Months-Change
Fundamentals
Return on Equity
-5.21%
Trailing 12-Months
Asset Growth
1.19%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Surgery Partners Inc
Surgery Partners, Inc. operates a nationwide network of surgical facilities and associated medical services across the United States. Its business is categorized into two segments: Surgical Facility Services and Ancillary Services. These surgical venues include both ambulatory surgery centers and dedicated surgical hospitals, delivering non-urgent surgical procedures across various specialties such as gastroenterology, general surgery, ophthalmology, orthopedics, and pain management. The surgical hospitals additionally offer comprehensive ancillary services, including diagnostic imaging, pharmacy, laboratory, obstetrics, oncology, physical therapy, and wound care. The dedicated Ancillary Services segment further encompasses multi-specialty physician practices, urgent care facilities, and anesthesia services. By December 31, 2021, the company's portfolio consisted of 126 surgical facilities—specifically, 108 ambulatory surgical centers and 18 surgical hospitals—situated across 31 states. Founded in 2004, Surgery Partners, Inc. maintains its headquarters in Brentwood, Tennessee.
SGRY Company Deck
SGRY Earnings Call
Q2 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call emphasized healthy organic performance (revenue growth, strong same-facility metrics, physician recruiting, case acuity expansion, sequential expense improvements) and a strategic portfolio optimization (Idaho Falls sale) expected to simplify the business, improve cash conversion and reduce leverage. Headwinds include a modest decline in adjusted EBITDA and margins year-to-date, higher interest expense, a ~350 bps decline in commercial mix, elevated leverage metrics, and muted M&A activity in 2026. On balance, the positives (organic growth, operational improvements, substantial deleveraging transaction and reaffirmed guidance) outweigh the negatives.View all SGRY earnings summariesSGRY Stock 12 Month Forecast
Average Price Target
$18.43
▲(31.16% Upside)
Technical Analysis
Community Health
―
HCA Healthcare
―
Tenet Healthcare
―
Universal Health
―
Ardent Health Partners, Inc.
―
Ownership Overview
1.64% Insiders
24.85% Mutual Funds
0.15% Other Institutional Investors
59.67% Public Companies and
Individual Investors